Please select from the following list of abstracts, representing the presentations given in Venice 2010 (IWWM-6) Session 9:
Phase II study of Rituximab and subcutaneous 2CDA in WM. Laszlo (Italy)
Phase I Study of Atacicept in relapsed/refractory MM and WM. Rossi (France)
Maintenance rituximab in WM. Ioakimidis (USA)
Update on Salvage Treatment Studies in WM (Part-1). Ghobrial (USA)
Update on Salvage Treatment Studies in WM (Part-2). Ghobrial (USA)
*** Special Guest Lecture ***
Novel Treatment Options for B-Cell Malignancies. Gregory (USA)










